Sebela Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Sebela Pharmaceuticals's estimated annual revenue is currently $51.9M per year.
- Sebela Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Sebela Pharmaceuticals has 258 Employees.
- Sebela Pharmaceuticals grew their employee count by -5% last year.
Sebela Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Chief Operating Officer and General Counsel | Reveal Email/Phone |
4 | CEO and President | Reveal Email/Phone |
5 | VP, Quality Operations | Reveal Email/Phone |
6 | VP, Regulatory Affairs & QA► FDA, Regulatory Strategy ★ Innovative Product Development | Reveal Email/Phone |
7 | Head R&D - Gastroenterology | Reveal Email/Phone |
8 | VP, Regulatory Affairs ► FDA, Regulatory Strategy ★ Innovative Product Development | Reveal Email/Phone |
9 | Head Corporate Development | Reveal Email/Phone |
10 | VP Market Access | Reveal Email/Phone |
Sebela Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2M | 20 | N/A | N/A | N/A |
What Is Sebela Pharmaceuticals?
Sebela Pharmaceuticals Inc. is committed to improving patients lives by developing, marketing and selling differentiated branded prescription pharmaceuticals that bring meaningful value to patients affected by gastrointestinal, dermatological and women's health diseases. To fulfill our commitment to improving patient's lives, we are continuing to grow our US commercial infrastructure, marketed product portfolio and late stage development pipeline in our core therapeutic areas. Our growth strategy includes in-licensing and acquiring late-stage drug candidates and marketed products that utilize and enhance our existing development and commercial capabilities. Sebela operates from two locations with an office in Roswell, Georgia, and headquarters in Dublin, Ireland.
keywords:Biotechnology,Healthcare,PharmaceuticalsN/A
Total Funding
258
Number of Employees
$51.9M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sebela Pharmaceuticals News
Apotex; Sebela Pharmaceuticals; Teva; Mylan; Sun Pharmaceutical; Lupin; Lannett Company; Aurobindo; Jubilant Pharma; Sciecure Pharma. Paroxetine...
The producers involved in the industry cover: Bausch Health; Allergan; Sebela Pharmaceuticals; Astellas Pharmaceuticals; Amneal Pharms; Pharscin Pharma. ACCESS...
... subsidiary of Sebela Pharmaceuticals which focuses on gastroenterology. ... In China, Shandong Luoxin Pharmaceutical Group seeks to win...
SUNNYVALE, Calif. and ROSWELL, Ga., March 23, 2021 /PRNewswire/ -- CellMax Life, a molecular diagnostics company with proprietary technology for pre-cancer and cancer detection blood tests, and Sebela Pharmaceuticals, a market leader in gastroenterology, announce the closing of a strategic devel ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $73.3M | 272 | 7% | N/A |
#2 | $92.2M | 289 | 7% | N/A |
#3 | $127.9M | 310 | 10% | N/A |
#4 | $58.2M | 321 | 1% | N/A |
#5 | $121.4M | 387 | 5% | N/A |